Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML |
Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML |
Boston Children’s Hospital / Alan Cantor, MD, PhD |
RARE Grant Program (Research Accelerating RUNX1 Exploration) |
2016 |
Massachusetts |
Development of a Screening Module to Assess Sibling-Related Psychosocial Risk in Families of Children with Cancer |
Boston University / Kristin Long, PhD |
Psychosocial Grants |
2014 |
Massachusetts |
Web-Based Cognitive-Behavioral Treatment for Insomnia in Adolescent Cancer Survivors |
Dana-Farber Cancer Institute / Eric Zhou, PhD |
Psychosocial Grants |
2016 |
Massachusetts |
Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma.
|
Massachusetts General Hospital / David Langenau |
Young Investigator Grants |
2009 |
Massachusetts |
Histone Modification and Hmgn1 Overexpression as Drivers of B-ALL with Polysomy 21 |
Dana-Farber Cancer Institute / Andrew Lane, MD, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
The Role of ARID1A in Neuroblastoma Pathogenesis |
Dana-Farber Cancer Institute / Hui Shi, PhD |
Young Investigator Grants |
2016 |
Massachusetts |
SWI/SNF Complex and Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Jennifer Wu |
Young Investigator Grants |
2012 |
Massachusetts |
The Therapy-Related Symptom Checklist for Children (TRSC-C): Systematic Monitoring of Symptoms to Improve Oncology Interventions.
|
Kansas Medical Center Research Institute, Inc. / Phoebe Williams |
Nurse Researcher Grants |
2008 |
Kansas |
Childhood Leukemia in Kenya Identified Through Malaria Slide Review |
Indiana University / Terry Vik |
Epidemiology Grants |
2012 |
Indiana |